robin shh's blog : Flow Cytometry Services Market Trends, Sales, Supply, Demand and Analysis by Forecast to 2035
Flow Cytometry Services industry – the rising realm amongst
stakeholders in pursuit of comprehensive cellular analysis and molecular
profiling.
The flow
cytometry services market (services) is estimated to be worth $2.76 billion
in 2022 and is expected to grow at compounded annual growth rate (CAGR) of
9.73% during the forecast period.
Owing to the incessant increase in disease incidence rates
and the lack of effective prognostics options, the diagnostics industry is
unable to cater to the growing demands across various therapeutic areas.
Interestingly, the recent developments in the diagnostics industry in the form
flow cytometry have been able to drive significant advances and innovation in
understanding the root causes of various diseases and their prognostics
procedures. Their popularity can be attributed to various factors, such as rapid
diagnosis, high result resolution and personalized nature. However, there are
several complexities associated with it, such as high cost, complicated
methodology and requirement of fully trained staff for operations. As a result,
outsourcing has emerged as an essential aspect and option in the flow cytometry
domain.
In the last few years, many contract service providers have
emerged and significantly impacted the overall flow cytometry market, which as
of now is characterized by the presence of only niche companies. Additionally,
outsourcing of research, services and analytical activities allows the sponsor
companies to focus on enhancing the flow cytometer as an instrument. Examples
of services that are commonly offered by contract service providers in this
domain are customized assay development, consumables such as dyes and buffers
manufacturing, analysis of PBMC, whole blood cells and bone marrow aspirate,
cell subsetting and characterization and rare cell detection.
Flow Cytometry Services
With the increase in the number of infections and diseases
around the globe, it has become necessary for the medical practitioners to
undertake analysis in a more dynamic and effective manner. And here’s where the
flow cytometers come in handy. This has led to the evolution of several
contract research organizations, which are currently undertaking analysis on
the behalf of researchers and medical teams through flow cytometers. Though
flow cytometers can be used in various domains, but specifically as of now, it
is being majorly used in the healthcare and immunology domain. Like, flow
cytometers are currently being used for diagnosis and detection of leukemia,
lymphoma and prognosis of HIV.
Various types of flow cytometric services that are currently
being offered by the stakeholders in this domain are Analytical
Flow Cytometry Services, General Flow Cytometry
Services and Other Types of Flow Cytometry Services.
In pursuit of a competitive edge, stakeholders are actively
expanding their existing capabilities to enhance their respective offerings and
comply with evolving industry benchmarks. The primary purpose of this analysis
was to develop a deeper understanding of the overall strength of the service
providers involved in this field. It allows companies to compare their existing
capabilities within their respective peer groups and identify ways to gain a
competitive edge in the industry. In addition, this analysis can be used by the
companies to ascertain improvement areas by identifying the gaps between their
existing capabilities and the best available practices in the industry.
In this analysis, we have analyzed all the companies and
plotted a four-dimensional bubble analysis with supplier strength on the
abscissa, service strength on the ordinate and facility strength as the size of
the bubble. The primary purpose of this analysis is to compare the popularity
and activity of different flow cytometry service providers on a relative basis.
At no point, should the discussion in this analysis be construed as a firm
recommendation that one service provider is better than the others. It is
important to mention that this analysis has been done based on the information
collated from various publicly available sources and the information disclosed
by the company.
Thank you for reading our report. Kindly get in touch with
us to know more about the report or to receive a customized copy of it. Our
team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech
market research. Having worked with over 750 clients worldwide, including
Fortune 500 companies, start-ups, academia, venture capitalists and strategic
investors for more than a decade, we offer a highly analytical / data-driven
perspective to a network of over 450,000 senior industry stakeholders looking
for credible market insights.
We specialise in analysing areas which have lacked quality
research so far or require more focused understanding within the broader
industry. All our reports are structured in a way to enable the reader develop
a thorough perspective on the given subject. Apart from writing reports on
identified areas, we also provide bespoke research / consulting services
dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The
leadership team brings a wealth of experience within the sector. Their
collective experience in pharmaceutical / affiliated domains allows us to
tackle various areas of research in a structured way. We also regularly
leverage our global network of experts who hold senior leadership positions in
reputed firms and organisations worldwide.
Contact:
Roots Analysis
Gaurav
Chaudhary
+1
(415) 800 3415
+44
(122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/